Antimicrobial composition
AssigneeFirmenich SA
InventorsMonica Bandera, Nicholas O'leary, Gary Marr
Life of this patent
Estimating the term…
Loading patent…
AssigneeFirmenich SA
InventorsMonica Bandera, Nicholas O'leary, Gary Marr
Estimating the term…
The present disclosure relates to the field of antimicrobial compositions. More particularly, it concerns the use of a composition as an antimicrobial agent, the composition comprising ingredients selected from the group consisting of: (i) nona-2,6-dien-1-ol in combination with at least one ingredient selected from the group consisting of 3-neopentylpyridine, 2-methylhexan-3-one oxime, terpineol and 2-isopropyl-5-methylphenol; (ii) gamma-dodecalactone in combination with at least one ingredient selected from the group consisting of 1-Methyl-4-(1-methylethenyl)-cyclohexene, 4-Methoxybenzaldehyde, and 1,3-Benzodioxole-5-carbaldehyde; (iii) (Z)-3,7-Dimethyl-2,6-octadien-1-ol and gamma-dodecalactone; (iv) cis-4(Isopropyl)cyclohexanemethanol and 4-Methoxybenzaldehyde; and (v) 1,3-Benzodioxole-5-carbaldehyde and 4-Methoxybenzaldehyde, wherein the ingredients are present in an amount sufficient to provide an antimicrobial effect. The composition and its use for the preparation of antimicrobially active perfuming compositions and consumer products are also objects of the disclosure.
A composition comprising gamma-dodecalactone in an amount between 25 ppm and 2000 ppm, and 1-methyl-4-(1-methylethenyl)-cyclohexene in an amount between 150 ppm and 500 ppm, wherein the ingredients are present in an amount sufficient to provide an antimicrobial effect, wherein the antimicrobial effect is an inhibition of growth of a bacterial strain selected from the group consisting of Corynebacterium xerosis, Staphylococcus aureus, and Escherichia coli.
Dependencies are inferred from the claim text.